Large Patient Network IDS serves over 150,000 physicians and 3,500 homecare providers, with a track record of over 2 million home-based oximetry and sleep tests, indicating a broad referral network and high-volume testing opportunities for compatible diagnostic tools and complementary services.

Acquisition Backstory IDS was acquired by VirtuOx in 2018, signaling integration into a broader health IT and diagnostic tools ecosystem, which may open opportunities for cross-sell of software, analytics, and interoperable testing solutions to VirtuOx clients.

Sleep & Oximetry Focus As the largest provider of overnight home pulse oximetry testing and an early direct-to-patient home sleep testing program for OSA, IDS presents ongoing needs for scalable devices, data integration, and demand-gen partnerships around home-based diagnostics.

Compliance & Scale Being Joint Commission accredited, Medicare-participating, and licensed as an IDTF with federal standards met positions IDS as a trusted partner for compliance-driven vendors seeking reliable deployment at scale in home health and ambulatory settings.

Tech Stack & Analytics Current technology stack includes analytics and tagging tools (Google Analytics, Tag Manager), server technologies, and web-based consent management, suggesting opportunities to offer enhanced data analytics, secure integrations, and privacy-compliant software solutions to optimize patient workflows.